Healthcare & Biotech
Arpeggio Bio
Arpeggio Bio develops drugs targeting transcription factors using AI…
Arpeggio Bio is a pioneering pharmaceutical company that develops drugs targeting transcription factors using AI and high-throughput RNA-sequencing. With $20M in venture funding, we've targeted "undruggable" proteins like NRF2, TEAD, and GPX4 where our lead program is rapidly progressing towards a DC for the treatment of IO-resistant…
- Drug Discovery and Delivery
- Biotech
- Genomics
- Website
- arpeggiobio.com
- Headquarters
- Boulder, CO, USA
- Team size
- 11-50 people
- Founded
- 2019
- Demo
- 45 min demo
Similar companies
Talus BioDiscovering drugs that target the DNA regulome
Sequence BioDiscovering the true signals of disease to power life-changing drugs.
Parallel BioUsing the immune system to cure disease
InvitrisCreating new protein-based drugs at scale
Avro Life ScienceSkin patches for generic drug delivery.
Adventris PharmaceuticalsAdventris makes cancer vaccines
Algen BiotechnologiesUsing CRISPR to find treatments for cancer and inflammation
General ProximityThe next generation of induced-proximity medicines.